Medical Device News Magazine

Interrad Medical and Eloquest Healthcare Partner to Expand U.S. Sales of SecurAcath

The partnership adds the revolutionary SecurAcath device to Eloquest Healthcare’s existing clinically oriented product offering

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Interrad Medical, Inc., a privately-held medical device company, announces it has formed a strategic partnership with Eloquest Healthcare to accelerate the growth of SecurAcath sales in the U.S.

Interrad Medical notes the companies will provide hospitals and clinicians with the proven benefits of the SecurAcath to improve outcomes and reduce total medical expenses.

“We are excited to have the SecurAcath included with Eloquest’s complimentary, problem-solving products,” said Joe Goldberger, President and CEO of Interrad Medical, Inc. “Eloquest Healthcare is known for delivering innovative solutions that improve the standard of care with an emphasis on infection prevention and improved patient care, making them an excellent partner for Interrad Medical.”

“Securement-related catheter complications, including infections and dislodgements, are unacceptably high,” said Tim O’Halla, President and CEO of Eloquest Healthcare. “Current catheter securement methods of sutures and adhesive devices have shown to have higher complication rates than the SecurAcath. The innovative SecurAcath device is a perfect fit with our mission to improve the standard of care while reducing total cost of patient care.”

The SecurAcath is the only subcutaneous catheter securement device in the world. Just one SecurAcath lasts the life of the line and can significantly reduce risk of catheter-related infections, dramatically decrease catheter dislodgement and migration, decrease catheter replacement costs, and lower total cost of patient care. SecurAcath has more positive clinical evidence and guidance support than any other catheter securement device.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”